VIA
NVAX icon

Virtus Investment Advisers’s Novavax NVAX Stock Holding History

Virtus Investment Advisers’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
130,955
+2,450
+2% +$22K 0.29% 173
2026
Q1 		$1.05M Buy
128,505
+24,486
+24% +$222K 0.29% 139
2025
Q4 		$699K Buy
104,019
+41,866
+67% +$316K 0.19% 165
2025
Q3 		$539K Hold
62,153
– – 0.15% 197
2025
Q2 		$392K Buy
62,153
+22,348
+56% +$148K 0.13% 227
2025
Q1 		$255K Buy
+39,805
New +$329K 0.07% 251

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Virtus Investment Advisers's NVAX Position: Q2 2026 in Review

Virtus Investment Advisers increased its Novavax (NVAX) stake by 1.9% in Q2 2026, buying an estimated $22K and bringing the position to 130,955 shares worth $1.23M. The position accounts for 0.29% of the portfolio, ranked #173.

Virtus Investment Advisers first reported a position in NVAX in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Virtus Investment Advisers held 130,955 shares of Novavax worth $1.23M as of Q2 2026.
  • Virtus Investment Advisers bought 2,450 Novavax shares in Q2 2026, an estimated $22K.
  • Novavax made up 0.29% of Virtus Investment Advisers's portfolio in Q2 2026, its #173 holding.
  • Virtus Investment Advisers first reported a position in Novavax in Q1 2025 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.